Active Substance & Generic Molecule Directory
Levofloxacin in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Levofloxacin registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
11
Registered Brands
Availability in Malaysia:11 Prescription (MAL-A)
Showing 11 of 11 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL17107077ARZ | Cravit 1.5% ophthalmic solution | 15mg 1ml | Prescription (MAL-A) | SANTEN PHARMA MALAYSIA SDN. BHD. | Compare → |
| MAL20041051AZ | CRAVIT 250MG | 250MG | Prescription (MAL-A) | RANBAXY (MALAYSIA) SDN. BHD. | Compare → |
| MAL20041052AZ | CRAVIT 500MG | 500MG | Prescription (MAL-A) | RANBAXY (MALAYSIA) SDN. BHD. | Compare → |
| MAL20040908ARZ | CRAVIT OPHTHALMIC SOLUTION | 5.00MG/ML | Prescription (MAL-A) | SANTEN PHARMA MALAYSIA SDN. BHD. | Compare → |
| MAL06030806AZ | Glevo Tablets 250 mg | 256.20 mg 0 | Prescription (MAL-A) | Glenmark Pharmaceuticals (Malaysia) Sdn. Bhd. | Compare → |
| MAL06030807AZ | Glevo Tablets 500 mg | 517.52 mg | Prescription (MAL-A) | Glenmark Pharmaceuticals (Malaysia) Sdn. Bhd. | Compare → |
| MAL09032008AZ | LEVOFLOXOL (Levofloxacin 5mg/mL Intravenous Infusion) | 5.125 mg ml | Prescription (MAL-A) | AIN MEDICARE SDN. BHD. | Compare → |
| MAL12095077AZ | Levoquin 250mg film coated caplet | 256mg | Prescription (MAL-A) | DKSH MALAYSIA SDN. BHD. | Compare → |
| MAL12095080AZ | Levoquin 500mg film coated caplet | 512mg | Prescription (MAL-A) | DKSH MALAYSIA SDN. BHD. | Compare → |
| MAL05061487AZ | LOXOF TABLETS 500mg | 512.45 mg 0 | Prescription (MAL-A) | RANBAXY (MALAYSIA) SDN. BHD. | Compare → |
| MAL11010021AZ | Olfovel 500mg Tablet | 512.5 mg | Prescription (MAL-A) | IMEKS PHARMA SDN. BHD. | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.